Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report)'s share price fell 1% during trading on Friday . The stock traded as low as $44.46 and last traded at $44.62. 23,381 shares were traded during mid-day trading, a decline of 31% from the average session volume of 33,707 shares. The stock had previously closed at $45.06.
Wall Street Analysts Forecast Growth
Separately, BNP Paribas cut Sandoz Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 2nd.
Check Out Our Latest Report on Sandoz Group
Sandoz Group Stock Performance
The company has a 50 day simple moving average of $43.09 and a two-hundred day simple moving average of $42.34.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
